Entegris, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENTG research report →
Range $167 – $220
Price Chart
About the company
Entegris, Inc. is a global enterprise that develops, manufactures, and supplies critical solutions for microcontamination control, specialty chemicals, and advanced material handling. The company operates extensively across North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia.
- CEO
- David W. Reeder
- IPO
- 2000
- Employees
- 7,700
- HQ
- Billerica, MA, US
AI snapshot
Six angles, distilled from the data.
ENTG is still in a corrective regime after a sharp multi-month reset from the 52-week high, but it remains well above the 52-week low. The stock is trading below both the 200-day and 50-day moving averages, so the setup favors a base-building phase rather than a clean uptrend.
Street sentiment is constructive: consensus sits at Buy with a $196 target, above the current price and supported by a $200 median target. Recent action has been mostly positive, with multiple initiations and target raises, including UBS at $220 and Citi at $195.
The earnings trend is favorable, with Entegris beating EPS in 6 of the last 8 quarters and the latest print topping estimates by 18.3%. Next-year EPS estimates point to $5.68 versus TTM EPS of $2.57, so shareholders should watch whether margin and demand momentum can sustain that step-up.
Recent insider activity leans to net selling, with several discretionary sales from senior officers and a director, while the other entries are award, exemption, or in-kind items that are not strong signal. The pattern does not show meaningful insider buying, so management appears more cautious than aggressive here.
Profitability is solid, with a 47.0% gross margin, 18.6% operating margin, and 11.1% net margin. Growth is strong too, with revenue up 24.6% year over year and earnings up 123.9%, while free cash flow reached $994.6 million in fiscal 2025.
Entegris screens as a higher-quality semiconductor materials name, with better margin structure than many cyclical hardware peers and exposure to contamination-control and process materials. The valuation remains rich versus the broader sector, at 38.79x earnings, so execution needs to stay clean.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.03B
- P/E
- 53.75
- Fwd P/E
- 28.34
- PEG
- 1.56
- P/S
- 5.99
- P/B
- 4.88
- EV/EBITDA
- 24.73
- Div Yield
- 0.29%
- Gross Margin
- 47.14%
- Op Margin
- 31.39%
- Net Margin
- 11.14%
- ROE
- 9.53%
- ROIC
- 12.50%
Latest fiscal year · YoY change
- Revenue
- $3.20B-1.4%
- Gross Profit
- $1.42B-4.5%
- Op Income
- $923.50M
- Net Income
- $235.60M-19.5%
- EPS
- $1.55-20.1%
- OCF Growth
- +10.1%
- FCF Growth
- +25.3%
- 52W High
- $186.94
- 52W Low
- $69.06
- 50D MA
- $147.64
- 200D MA
- $140.00
- Beta
- 1.40
- RSI (14)
- 45
- Avg Volume
- 2.65M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Entegris posted record Q3 sales above $1 billion with strong margin expansion, driven by solid demand, better execution, and improved capacity utilization.· October 29, 2026
- Q3 revenue reached a record $1.006 billion, up 25% year over year and 14% sequentially, with non-GAAP EPS up 71% to $1.23.
- Adjusted gross margin improved to 48.9%, up 530 basis points year over year, and adjusted EBITDA margin reached 30.2%.
- Growth was broad-based: APS sales rose 31% year over year to $605 million and MS sales rose 16% to $404 million.
- Management said the quarter benefited heavily from execution and throughput gains that converted backlog into revenue, not from material pricing.
- Balance sheet and cash flow improved meaningfully: record free cash flow was $224 million, net leverage fell to 2.9x, and the 2029 term loan was fully repaid.
Entegris reported Q3 2026 record sales of $1.006 billion, up 25% year over year and 14% sequentially. GAAP gross margin was 49.7% and adjusted gross margin was 48.9%, up 530 basis points year over year and 130 basis points sequentially. GAAP diluted EPS was $1.03 and non-GAAP EPS was $1.23, up 71% year over year; GAAP net income was $158 million and non-GAAP net income was $190 million. Adjusted EBITDA was $303 million, or 30.2% of sales, and record free cash flow was $224 million. For Q4, the company guided sales to $1.025 billion to $1.055 billion, gross margin to 49.2% to 49.7%, GAAP EPS to $1.09 to $1.17, and non-GAAP EPS to $1.32 to $1.40. For 2026, CapEx is expected to be about $200 million, or about one-third lower than last year. For Q1, management said revenue should decline by a mid-single-digit percentage versus Q4 but remain up more than 20% year over year.
Dave Reeder’s tone was upbeat and confident, emphasizing that the quarter showed both strong end-market demand and better internal execution. He said demand remains strong across advanced logic, advanced memory, and the broader semiconductor ecosystem, supported by AI infrastructure spending, and highlighted earlier customer engagement, more plan-of-record wins, and better conversion of backlog into revenue. He also pointed to operational progress across manufacturing output, yield, procurement, and capacity utilization, saying the team is strengthening Entegris’ ability to turn demand into revenue.
Sukhi Nagesh focused on the operating leverage in the model and tied the quarter’s performance to higher volume, fixed-cost absorption, improved yield, and productivity. He cited adjusted gross margin of 48.9%, adjusted EBITDA margin of 30.2%, non-GAAP EPS of $1.23, and record free cash flow of $224 million, noting that the quarter also enabled full repayment of the term loan and reduced net leverage to 2.9x. He said Q4 gross margin should stay in a 49.2% to 49.7% range, with non-GAAP operating expenses around $227 million at the midpoint, and reiterated that 2026 CapEx should be about $200 million.
Analysts pressed management on whether the beat was driven more by demand or supply, and Reeder said it was mainly execution: production and throughput increased beyond expectations, allowing the company to convert backlog into revenue. Questions also focused on how much of the growth can persist into 2027, with management saying the setup remains constructive, but cautioning that Q1 will reflect normal seasonality and fewer selling days. On capacity and constraints, Reeder said the company has significant embedded capacity, is working through some pinch points, and feels good about supplier readiness, while also noting that KSP South reached breakeven in Q3 and Colorado is currently producing samples with revenue expected next year.
The call suggested that demand is broadening and becoming more visible, with strong backlog, book-to-bill well above 1, and customer planning horizons lengthening. Management believes AI-related investment, advanced-node transitions, and rising contamination-control requirements should support further content gains, while operational improvements are lifting margins and cash flow without relying on pricing.
Near-term growth may still be constrained by normal seasonality, fewer Q1 selling days, and ongoing supply-chain or manufacturing pinch points that management said it will need to keep working through. The company also acknowledged some facilities remain dilutive or still ramping, and management said Q1 revenue should step down sequentially even though year-over-year growth remains strong.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.4%
- Shares Outstanding
- 152.80M
- Float Shares
- 151.87M
of shares held by institutions
786 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ENTG, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| April McClain DelaneyHouse · MD06 | Sell | Aug 25, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | Jul 8, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | Jul 30, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | Jun 5, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | Jun 8, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | May 21, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | May 8, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | May 7, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | Apr 15, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Buy | Mar 31, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Feb 9, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Feb 23, 26 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Oct 30, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Oct 31, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 19.95M | ▼ 530.48K |
| Vanguard Group Inc | 15.75M | ▼ 269.05K |
| Price T Rowe Associates Inc | 14.47M | ▲ 1.67M |
| Capital Research Global Investors | 11.20M | ▼ 9.38K |
| Vanguard Portfolio Management LLC | 7.59M | ▼ 191.55K |
| Vanguard Capital Management LLC | 6.88M | ▼ 12.88K |
| Principal Financial Group Inc | 5.70M | ▼ 259.61K |
| State Street Corp | 5.60M | ▲ 74.68K |
| Fmr LLC | 5.59M | ▲ 3.31M |
| Jpmorgan Chase & Co | 5.21M | ▼ 313.46K |
| Invesco Ltd. | 3.48M | ▼ 2.15M |
| Primecap Management Co | 3.17M | ▲ 43.48K |
Held by 1,080 ETFs
Biggest fund positions in ENTG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 18, 26 | Reeder David | other | 5,386 |
| Aug 14, 26 | Blachier Olivier | other | 2,000 |
| Aug 14, 26 | Blachier Olivier | sell | 2,000 |
| Aug 14, 26 | Blachier Olivier | other | 2,000 |
| Aug 13, 26 | Colella Joseph | other | 3,916 |
| Aug 13, 26 | Colella Joseph | sell | 3,916 |
| Aug 13, 26 | Colella Joseph | other | 3,916 |
| Aug 11, 26 | Rice Susan G. | sell | 2,062 |
| Aug 4, 26 | LOY BERTRAND | other | 0 |
| Aug 3, 26 | BRUGGEWORTH ROBERT A | other | 1,329 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ENTG coverage
Recent articles, reports, and earnings notes.

TeraQuake, Revealed: Every Stock Brian Hicks Is Teasing in R.I.C.H. Report
Brian Hicks of Angel Publishing’s Outsider Club is pitching The TeraQuake, also called TeraQuake Toll Booths, through the R.I.C.H. Report. We identify the three companies and test the chip-plant thesis against filings.

Forge Nano Holdings IPO: What Investors Need to Know
Forge Nano Holdings Inc. Common Stock (NASDAQ: NANO) is expected to list on 2026-10-22, but the company has not disclosed a conventional price range. This is a priced SPAC business combination, not a traditional underwritten IPO. The setup favors investors who want exposure to battery and semiconductor materials, but the deal still carries early-commercialization and financing risk.

Entegris may be the AI chip trade’s quietest breakout
Entegris looks like one of the cleanest picks-and-shovels ways to play AI chip complexity, and the market is finally treating it that way. The stock’s breakout is backed by improving advanced-node demand, a strong Q1 beat, and a Momentum component of 100 inside the TickerSpark Score.
Want a deeper read on ENTG?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
6,361 Shares of Entegris, Inc. $ENTG Purchased by Banco Santander S.A.
defenseworld.net · Nov 20
Entegris, Inc. $ENTG Stock: Bessemer Group Inc. Boosts Holdings
defenseworld.net · Nov 17
Surging Earnings Estimates Signal Upside for Entegris (ENTG) Stock
zacks.com · Nov 16
Wall Street Analysts Believe Entegris (ENTG) Could Rally 27.44%: Here's is How to Trade
zacks.com · Nov 16
Buy 3 AI Semiconductor Equipment Stocks to Tap Huge Market Opportunity
zacks.com · Nov 13
Entegris, Inc. $ENTG Shares Newly Bought by CenterBook Partners LP
defenseworld.net · Nov 12
Entegris, Inc. (ENTG) Analyst/Investor Day Transcript
seekingalpha.com · Nov 10
Entegris Details Growth Strategy and Long-Term Financial Model at 2026 Capital Markets Day
businesswire.com · Nov 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 21, 2026 · Live quote · Not investment advice